Patents by Inventor Lijuan WU
Lijuan WU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 12372154Abstract: A sealing device of a bearing. The sealing device includes a framework, a sealing component and a plurality of elastic members, wherein the framework and the sealing component are both annular and connected to each other, and the framework is configured to be fixed to a first ring of a bearing. The sealing component is configured to abut against a second ring of the bearing the plurality of elastic members are distributed at intervals in the circumferential direction of the sealing component, and the elastic members are used for applying an elastic force to the sealing component such that the sealing component is pressed against the second ring. A bearing is also provided.Type: GrantFiled: October 16, 2020Date of Patent: July 29, 2025Assignee: Schaeffler Technologies AG & Co. KGInventors: Xin Liu, Lijuan Wu, Yu Tang, Jia Fan, Chunliang Huang, Jianfei Wei
-
Patent number: 12364682Abstract: The present disclosure discloses the use of Tegaserod or a pharmaceutically acceptable salt thereof as a JAK-STAT3 signaling pathway inhibitor and an immunomodulator in the preparation of an anti-tumor drug. Tegaserod and the pharmaceutically acceptable salt thereof show a very excellent inhibitory effect on the growth of various tumor cells in vivo and in vitro, and are expected to be used in the treatment of various cancers.Type: GrantFiled: April 17, 2020Date of Patent: July 22, 2025Assignees: Qingdao Haiji Biomedicine Co., Ltd., MARINE BIOMEDICAL RESEARCH INSTITUTE OF QINGDAO CO., LTD.Inventors: Jinbo Yang, Qiaoling Song, Chenyang Zhao, Lijuan Wu, Jun Zhao, Dan Yao, Yu Tang, Ximing Xu, Menglin Yang
-
Patent number: 12357654Abstract: An application of a glucan in the preparation of a drug. A ?-1,3/1,6-glucan is used for preparing a pharmaceutical composition or formulation. The pharmaceutical composition or formulation can enhance the antitumor effect of immunotherapy, radiotherapy, or chemotherapy, and is used for treating leukopenia and/or thrombocytopenia.Type: GrantFiled: June 15, 2020Date of Patent: July 15, 2025Assignees: QINGDAO CONSON PHARMACEUTICAL CO., LTD., MARINE BIOMEDICAL RESEARCH INSTITUTE OF QINGDAO CO., LTD.Inventors: Jinbo Yang, Guangli Yu, Qiaoling Song, Lijuan Wu, Jun Zhao, Youjing Lv, Chenyang Zhao, Huashi Guan
-
Publication number: 20250146574Abstract: A sealing device, comprising includes a sealing ring including a sealing lip composed of an insulating elastic material for forming dynamic sealing with respect to a conductive component; a support body fixed on the sealing ring along the circumferential direction of the sealing ring, and a first detection unit comprising two first support bodies in the support body, first cables respectively electrically connected to the corresponding first support bodies, and a loop detection device electrically connected to the first cables, wherein the first support bodies are arranged at the sealing ring such that radial ends of the first support bodies close to the conductive component are covered with the insulating elastic material at the sealing lip and can directly contact the conductive component after the sealing lip is worn. The two first support bodies, the conductive component, the loop detection device, and the first cables jointly form a communication loop.Type: ApplicationFiled: February 8, 2022Publication date: May 8, 2025Inventors: Xin Liu, Lijuan Wu, Lai Wei, Jianfei Wei
-
Publication number: 20240418265Abstract: A sealing device. The sealing device includes an elastic sealing body. The clastic sealing body has a first end and a second end, the elastic sealing body extends from the first end to the second end, and the first end and the second end can be detachably joined together to form a closed loop. The sealing device is easy to mount.Type: ApplicationFiled: September 13, 2022Publication date: December 19, 2024Applicant: Schaeffler Technologies AG & Co. KGInventors: Xin LIU, Lijuan Wu, Chuliang HUANG, Yu TANG, Xu ZHAO
-
Publication number: 20240141955Abstract: A bearing and a sealing device. The sealing device includes: a skeleton; and a sealing part, which, taken as a whole, is of an annular structure, the sealing part comprising an elastic part and a plastic part, and the elastic part being fixed to the skeleton. After the sealing device is arranged between a bearing inner ring and a bearing outer ring, the plastic part and the bearing inner ring form contact sealing, the elastic part and the plastic part are relatively fixed, and in the radial direction, at least part of the plastic part is arranged between the bearing inner ring and the elastic part. The coefficient of friction of the material of the plastic part is smaller than the coefficient of friction of the material of the elastic part.Type: ApplicationFiled: January 8, 2022Publication date: May 2, 2024Applicant: Schaeffler Technologies AG & Co. KGInventors: Xin LIU, Lijuan WU, Jianchang ZHANG, Aoran QIN, Ding LI
-
Publication number: 20230392649Abstract: A sealing device of a bearing. The sealing device includes a framework, a sealing component and a plurality of elastic members, wherein the framework and the sealing component are both annular and connected to each other, and the framework is configured to be fixed to a first ring of a bearing. The sealing component is configured to abut against a second ring of the bearing the plurality of elastic members are distributed at intervals in the circumferential direction of the sealing component, and the elastic members are used for applying an elastic force to the sealing component such that the sealing component is pressed against the second ring. A bearing is also provided.Type: ApplicationFiled: October 16, 2020Publication date: December 7, 2023Applicant: Schaeffler Technologies AG & Co. KGInventors: Xin LIU, Lijuan WU, Yu TANG, Jia FAN, Chunliang HUANG, Jianfei WEI
-
Publication number: 20230346777Abstract: The invention relates to substituted pyrazolo piperidine carboxylic acids, their salts and their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular of ophthalmologic diseases, including non-proliferative diabetic retinopathy (NPDR), diabetic macular edema (DME), retinal ganglion cell/photoreceptor neurodegeneration and cataract.Type: ApplicationFiled: April 14, 2023Publication date: November 2, 2023Inventors: William Ernst SCHUBERT, Khaled NASSAR, Peter SANDNER, Carsten TERJUNG, Elia DUH, Hongkwan CHO, Zhenhua XU, Lijuan WU, Lingli ZHOU
-
Publication number: 20220331352Abstract: An application of a glucan in the preparation of a drug. A ?-1,3/1,6-glucan is used for preparing a pharmaceutical composition or formulation. The pharmaceutical composition or formulation can enhance the antitumor effect of immunotherapy, radiotherapy, or chemotherapy, and is used for treating leukopenia and/or thrombocytopenia.Type: ApplicationFiled: June 15, 2020Publication date: October 20, 2022Inventors: Jinbo YANG, Guangli YU, Qiaoling SONG, Lijuan WU, Jun ZHAO, Youjing LV, Chenyang ZHAO, Huashi GUAN
-
Publication number: 20220241273Abstract: The invention relates to substituted pyrazolo piperidine carboxylic acids, their salts and their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular of ophthalmologic diseases, including non-proliferative diabetic retinopathy (NPDR), diabetic macular edema (DME), retinal ganglion cell/photoreceptor neurodegeneration and cataract.Type: ApplicationFiled: February 8, 2022Publication date: August 4, 2022Inventors: William Ernst SCHUBERT, Khaled NASSAR, Peter SANDNER, Carsten TERJUNG, Elia DUH, Hongkwan CHO, Zhenhua XU, Lijuan WU, Lingli ZHOU
-
Publication number: 20220218666Abstract: The present disclosure discloses the use of Tegaserod or a pharmaceutically acceptable salt thereof as a JAK-STAT3 signaling pathway inhibitor and an immunomodulator in the preparation of an anti-tumor drug. Tegaserod and the pharmaceutically acceptable salt thereof show a very excellent inhibitory effect on the growth of various tumor cells in vivo and in vitro, and are expected to be used in the treatment of various cancers.Type: ApplicationFiled: April 17, 2020Publication date: July 14, 2022Applicant: MARINE BIOMEDICAL RESEARCH INSTITUTE OF QINGDAO CO., LTD.Inventors: Jinbo YANG, Qiaoling SONG, Chenyang ZHAO, Lijuan WU, Jun ZHAO, Dan YAO, Yu TANG, Ximing XU, Menglin YANG
-
Patent number: 11057234Abstract: The present disclosure provides a device control method and apparatus. The device control method includes: connecting to a current LAN and searching a device in the LAN; determining whether there is a created device management group corresponding to the device or more, wherein the device management group corresponds to one or more devices; when there is a created device management group, determining whether there is an account bound to the device management group; and when there is no account bound to the device management group, binding a current account of a user to the device management group, thereby obtaining control of the device corresponding to the device management group according to a binding relationship between the current account of the user and the device management group.Type: GrantFiled: July 25, 2018Date of Patent: July 6, 2021Assignee: SHENZHEN ORVIBO TECHNOLOGY CO.. LTDInventors: Lijuan Wu, Hailiang He
-
Patent number: 10731706Abstract: A box type sealing structure including an oil throwing ring and sealing ring with a frame and sealing portion attached to the frame, the oil throwing ring including a centrifugal structure.Type: GrantFiled: May 27, 2017Date of Patent: August 4, 2020Assignee: Schaeffler Technologies AG & Co. KGInventors: Xiaoyi Shi, Hongwei Song, Zhiheng Liu, Gilson Arima, Uwe Niebling, Fuqiang Cai, Xin Liu, Lijuan Wu
-
Publication number: 20200186370Abstract: The present disclosure provides a device control method and apparatus. The device control method includes: connecting to a current LAN and searching a device in the LAN; determining whether there is a created device management group corresponding to the device or more, wherein the device management group corresponds to one or more devices; when there is a created device management group, determining whether there is an account bound to the device management group; and when there is no account bound to the device management group, binding a current account of a user to the device management group, thereby obtaining control of the device corresponding to the device management group according to a binding relationship between the current account of the user and the device management group.Type: ApplicationFiled: July 25, 2018Publication date: June 11, 2020Inventors: LIJUAN WU, HAILIANG HE
-
Publication number: 20190257361Abstract: A box type sealing structure including an oil throwing ring and sealing ring with a frame and sealing portion attached to the frame, the oil throwing ring including a centrifugal structure.Type: ApplicationFiled: May 27, 2017Publication date: August 22, 2019Applicant: Schaeffler Technologies AG & Co. KGInventors: Xiaoyi Shi, Hongwei Song, Zhiheng Liu, Gilson Arima, Uwe Niebling, Fuqiang Cai, Xin Liu, Lijuan Wu
-
Patent number: 9695076Abstract: A method for reducing release of resistance genes during sludge anaerobic treatment includes controlling concentration of to-be-treated sludge in a concentration tank to be 12-20 g/L by sedimentation under gravity. The concentrated sludge is transferred to a supersonic pre-treatment device to proceed with supersonic pre-treatment. The supersonic pre-treatment is conducted for 5-30 minutes at a power of 0.1-0.5 kW and a frequency of 10-40 kHz. The pre-treated sludge is then transferred to an anaerobic treatment device for anaerobic treatment. The anaerobic treatment is conducted for 4-12 days at a temperature of 20-37° C. The release amount of resistance genes in the residual sludge and the supernatant liquid in the anaerobic treatment device is detected. A feedback dosage of an alkali liquid is fed into the anaerobic treatment device according to the release amount of the resistance genes, controlling a pH value to be 9.0-11.0 during the anaerobic treatment.Type: GrantFiled: November 2, 2015Date of Patent: July 4, 2017Assignee: Tongji UniversityInventors: Yinguang Chen, Xiong Zheng, Haining Huang, Yinglong Su, Mu Li, Lijuan Wu
-
Publication number: 20160229727Abstract: A method for reducing release of resistance genes during sludge anaerobic treatment includes controlling concentration of to-be-treated sludge in a concentration tank to be 12-20 g/L by sedimentation under gravity. The concentrated sludge is transferred to a supersonic pre-treatment device to proceed with supersonic pre-treatment. The supersonic pre-treatment is conducted for 5-30 minutes at a power of 0.1-0.5 kW and a frequency of 10-40 kHz. The pre-treated sludge is then transferred to an anaerobic treatment device for anaerobic treatment. The anaerobic treatment is conducted for 4-12 days at a temperature of 20-37° C. The release amount of resistance genes in the residual sludge and the supernatant liquid in the anaerobic treatment device is detected. A feedback dosage of an alkali liquid is fed into the anaerobic treatment device according to the release amount of the resistance genes, controlling a pH value to be 9.0-11.0 during the anaerobic treatment.Type: ApplicationFiled: November 2, 2015Publication date: August 11, 2016Inventors: Yinguang Chen, Xiong Zheng, Haining Huang, Yinglong Su, Mu Li, Lijuan Wu
-
Publication number: 20130278547Abstract: An electronic device includes a touch sensor, a touch sensor, and a controller. The touch sensor is configured for detecting a touch action on a touchscreen and reporting touch information. The proximity sensor is configured for detecting nearness of a target object and reporting a proximity information. The controller is connected to the touch sensor and the proximity sensor, the touch sensor and the proximity sensor are putted in a same circuit, such that the touch sensor and the proximity sensor are controlled by the same controller. When the proximity sensor detecting nearness of the target object, the controller will prevent touch report event.Type: ApplicationFiled: August 7, 2012Publication date: October 24, 2013Applicant: SHENZHEN TOPSENSING ELECTRONIC TECHNOLOGY CO., LTDInventors: Lijuan WU, Haohui Zhang, Yi Li, Yicheng Xiang